Hypoxaemia detection and management for at-risk newborns and children in Sub-Saharan Africa
- Funded by National Health and Medical Research Council (NHMRC)
- Total publications:0 publications
Grant number: GA206723
Grant search
Key facts
Disease
COVID-19Start & end year
20222026Known Financial Commitments (USD)
$452,661.42Funder
National Health and Medical Research Council (NHMRC)Principal Investigator
N/A
Research Location
AustraliaLead Research Institution
Murdoch Childrens Research InstituteResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Children (1 year to 12 years)Newborns (birth to 1 month)
Vulnerable Population
Unspecified
Occupations of Interest
Not applicable
Abstract
Low blood oxygen levels (hypoxaemia) are common in COVID-19, pneumonia, and many other illnesses. In low-resource settings, many patients who need oxygen will not receive it, and could die. My research aims to make oxygen more accessible and safe to patients, particularly small newborns, children, and people living in remote locations. I will test a new device to deliver oxygen to babies more safely, and test whether introducing pulse oximetry to small clinics saves lives.